Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Autacoids And Related Drug Market?

The market for autacoids and associated drugs has experienced considerable growth in prior years. Its value is expected to amplify from $50.15 billion in 2024 to $52.81 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this historic growth include a rise in inflammatory diseases, increased use of prostaglandins for obstetrical needs, the prevalent prescription of antihistamines, the growing uses of serotonin agonists, and a boost in the need for migraine medications.

The market size for autacoids and associated drugs is anticipated to experience substantial growth in the forthcoming years, escalating to a staggering “$66.2 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. The significant growth anticipated during this projection period can be ascribed to factors such as an increasing elderly population, the rising occurrence of chronic respiratory diseases, the acceptance of personalized medicine, expanded healthcare access in developing economies, and an increased rate of cardiovascular diseases. Key trends projected for this period encompass the integration of artificial intelligence in drug discovery, the creation of dual-action autacoid medications, the utilization of biosimilars for autacoid therapies, the rise in self-medication and over-the-counter products, and the implementation of nanotechnology in drug formulation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

What Underlying Factors Are Supporting The Autacoids And Related Drug Market Growth?

The rise in cardiovascular diseases is anticipated to fuel the expansion of the autacoids and related drugs market in the future. These diseases encompass a range of disorders that affect the heart and blood vessels, including coronary heart disease, heart failure, stroke, and high blood pressure. A primary factor contributing to the increase in cardiovascular diseases is an unhealthy diet mainly marked by high consumption of saturated fats, trans fats, extra sugars, and sodium. Such diets elevate blood pressure and cholesterol levels and promote obesity, all prominent risk factors for heart complications. Autacoids and related medicines work to improve cardiovascular health by adjusting vascular tone and inflammation, which are significant elements in conditions like hypertension and heart failure. Drugs targeting pathways that involve nitric oxide, endothelin, and prostacyclin aid in regenerating endothelial function, triggering vasodilation, and reducing vascular resistance. In support of this, the Australian Institute of Health and Welfare reported an increase from 14,100 in 2021 to 14,900 in 2022 in doctor-certified deaths in Australia due to coronary heart disease (CHD) in December 2023. As a result, the rise in cardiovascular diseases is stimulating the growth of the autacoids and related drugs market.

What Are The Main Segment Classifications In The Autacoids And Related Drug Market?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

How Are Industry Trends Steering The Expansion Of The Autacoids And Related Drug Market?

Major players in the autacoids and related drugs market are concentrating on the creation of innovative products like antihistamines to boost therapeutic potency, minimise side effects, and more accurately and safely address emerging allergies and inflammatory conditions. Antihistamines serve to counteract the impact of histamine, a chemical released amid an allergic response by your immune system. To illustrate, Tiefenbacher Pharmaceuticals, a pharmaceutical company located in Germany, introduced Bilastine as an over-the-counter drug in Germany in March 2023, this was a crucial advancement in making effective allergy treatments more accessible. These 20 mg Bilastine tablets provide a non-sedating, second-generation antihistamine solution for patients dealing with allergy-related conditions such as hay fever and urticaria.

Which Firms Are Driving Innovation Within The Autacoids And Related Drug Market?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report

What Are The Emerging Regional Trends Driving The Autacoids And Related Drug Market?

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model